Integrated Filing — IndAS



General information about company

Scrip Code 543213
NSE Symbol ROSSARI
MSEI Symbol NOTLISTED
ISIN INE02A801020
Name of company ROSSARI BIOTECH LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 17-10-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 09-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Manufacturing of Specialty Chemicals for Textile, Home and Personal Care, Performance Chemicals and Animal Health and Nutrition industries
Start date and time of board meeting 17-10-2026   17:48:00
End date and time of board meeting 17-10-2026   18:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 27-04-2026
Indicate Company website link for updated RPT policy of the Company www.rossari.com/corporate-governance/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 49,527.60 97,755.10
Other income 168.60 387.40
Total income 49,696.20 98,142.50
2 Expenses
(a) Cost of materials consumed 31,453.50 60,892.90
(b) Purchases of stock-in-trade 7,849.60 15,404.70
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (2,142.50) (3,516.90)
(d) Employee benefit expense 2,088.20 4,126.90
(e) Finance costs 207.70 592.00
(f) Depreciation, depletion and amortisation expense 1,073.30 1,906.90
(f) Other Expenses
1 Other Expenses 4,551.10 9,478.60
Total other expenses 4,551.10 9,478.60
Total expenses 45,080.90 88,885.10
3 Total profit before exceptional items and tax 4,615.30 9,257.40
4 Exceptional items 0.00 0.00
5 Total profit before tax 4,615.30 9,257.40
6 Tax expense
7 Current tax 1,202.80 2,401.60
8 Deferred tax (10.60) 6.10
9 Total tax expenses 1,192.20 2,407.70
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 3,423.10 6,849.70
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 3,423.10 6,849.70
17 Other comprehensive income net of taxes (1.30) (2.50)
18 Total Comprehensive Income for the period 3,421.80 6,847.20
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,107.90 1,107.90
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 6.18 12.37
Diluted earnings (loss) per share from continuing operations 6.18 12.36
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 6.18 12.37
Diluted earnings (loss) per share from continuing and discontinued operations 6.18 12.36
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The value of the related party transaction approved by the audit committee represents the value approved by audit committee of the respective company, as applicable. 2. Remuneration does not include stock options granted in accordance with the Rossari Employee Stock Option Plan- 2019, these options would vest after fulfilment of vesting conditions in accordance with the plan. Remuneration reported pertains to the amount paid during the period. 3. Transactions between members of the Group (between Rossari Biotech Limited and its subsidiary or between subsidiaries) are reported once. 4. The related transactions have been valued at the Average rate for the half year ended 30th September Further all the closing balances are valued at Closing rate as on 30th September 2026. (wherever necessary). 5.. For transactions between foreign subsidiaries, the conversion rate as on September 30, 2026 was applied.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 20,952.00
Capital work-in-progress 7,867.20
Investment property
Goodwill 106.00
Other intangible assets 4,424.30
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 51,250.80
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other Financial Assets 343.30
Total of other non-current financial assets 343.30
Total non-current financial assets 51,594.10
Deferred tax assets (net) 326.20
Other non-current assets
1 Income Tax Assets (Net) 526.20
2 Other non-current assets 1,071.80
Total of other non-current assets 1,598.00
Total non-current assets 86,867.80
2 Current assets
Inventories 20,378.70
Current financial asset
Current investments 3,002.20
Trade receivables, current 52,436.30
Cash and cash equivalents 6,698.30
Bank balance other than cash and cash equivalents 389.80
Loans, current 4,098.00
Other current financial assets
Total of other current financial assets 2,654.60
Total current financial assets 69,279.20
Current tax assets (net)
Other current assets
1 Other current assets 3,411.00
Total of other current assets 3,411.00
Total current assets 93,068.90
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,79,936.70
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,107.90
Other equity 1,27,507.70
Total equity attributable to owners of parent 1,28,615.60
Non controlling interest
Total equity 1,28,615.60
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 461.10
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease Liabilities 1,128.70
Total of other non-current financial liabilities 1,128.70
Total non-current financial liabilities 1,589.80
Provisions, non-current 592.30
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 2,182.10
Current liabilities
Current financial liabilities
Borrowings, current 8,053.70
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,315.20
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 34,260.90
Total Trade payable 36,576.10
Other current financial liabilities
1 Lease Liabilities 445.00
2 Other financial liabilities 1,916.50
Total of other current financial liabilities 2,361.50
Total current financial liabilities 46,991.30
Other current liabilities 880.80
1 Other current liabilities 880.80
Total of other current liabilities 880.80
Provisions, current 400.20
Current tax liabilities (Net) 866.70
Deferred government grants, Current
Total current liabilities 49,139.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 51,321.10
Total equity and liabilites 1,79,936.70
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the defined benefit plans (1.70) (3.30)
Total Amount of items that will not be reclassified to profit and loss (1.70) (3.30)
2 Income tax relating to items that will not be reclassified to profit or loss (0.40) (0.80)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (1.30) (2.50)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 9,257.40
Adjustments for reconcile profit (loss)
Adjustments for finance costs 632.40
Adjustments for decrease (increase) in inventories (2,406.00)
Adjustments for decrease (increase) in trade receivables, current 714.40
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 570.80
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,906.90
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 235.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (0.90)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 226.60
Adjustments for dividend income 0.00
Adjustments for interest income 186.10
Adjustments for share-based payments 85.90
Adjustments for fair value losses (gains) (47.30)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (75.30)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 4.90
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 1,661.30
Net cash flows from (used in) operations 10,918.70
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 2,152.50
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 8,766.20
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 542.80
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 28.80
Purchase of property, plant and equipment 2,382.30
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 140.10
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (7.50)
Net cash flows from (used in) investing activities (1,678.10)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 45.70
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 4,136.20
Payments of lease liabilities 265.70
Dividends paid 277.00
Interest paid 596.50
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (5,229.70)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 1,858.40
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents (24.90)
Net increase (decrease) in cash and cash equivalents 1,833.50
Cash and cash equivalents cash flow statement at beginning of period 4,864.80
Cash and cash equivalents cash flow statement at end of period 6,698.30





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Rossari Biotech Limited Sunil Chari Key Managerial Personnel Remuneration As per the Companies Act, 2013 and Shareholders' Approval 28.40 0.00 0.00
2 Rossari Biotech Limited Edward Menezes Key Managerial Personnel Remuneration As per the Companies Act, 2013 and Shareholders' Approval 28.40 0.00 0.00
3 Rossari Biotech Limited Mikhail Menezes Relative of Director Remuneration As per the Companies Act, 2013 and Shareholders' Approval 53.70 0.00 0.00
4 Rossari Biotech Limited Yash Chari Relative of Director Remuneration As per the Companies Act, 2013 and Shareholders' Approval 5.80 0.00 0.00
5 Rossari Biotech Limited Ketan Sablok Key Managerial Personnel Remuneration As per the Companies Act, 2013 and Shareholders' Approval 146.90 0.00 0.00
6 Rossari Biotech Limited Parul Gupta Key Managerial Personnel Remuneration As per the Companies Act, 2013 and Shareholders' Approval 22.50 0.00 0.00
7 Rossari Biotech Limited Rupesh Ruparelia Key Managerial Personnel Remuneration As per the Companies Act, 2013 and Shareholders' Approval 30.30 0.00 0.00
8 Rossari Biotech Limited Aseem Dhru Independent Director Any other transaction Sitting Fees NA 5.00 0.00 0.00
9 Rossari Biotech Limited Gurudas Aras Independent Director Any other transaction Sitting Fees NA 9.00 0.00 0.00
10 Rossari Biotech Limited Aparna Sharma Independent Director Any other transaction Sitting Fees NA 4.00 0.00 0.00
11 Rossari Biotech Limited Esha Achan Independent Director Any other transaction Sitting Fees NA 9.00 0.00 0.00
12 Rossari Biotech Limited Udeypaul Singh Gill Independent Director Any other transaction Sitting Fees NA 4.00 0.00 0.00
13 Rossari Biotech Limited Buzil Rossari Private Limited Wholly Owned Subsidiary Company Sale of goods or services 7,500.00 NA 2,173.20 8,022.90 10,126.50
14 Rossari Biotech Limited Buzil Rossari Private Limited Wholly Owned Subsidiary Company Purchase of goods or services 300.00 NA 9.90 2.30 113.40
15 Rossari Biotech Limited Buzil Rossari Private Limited Wholly Owned Subsidiary Company Loan 5,000.00 NA 0.00 2,400.00 2,400.00 Loan 8.00 On Demand Unsecured General Business Requirement
16 Rossari Biotech Limited Buzil Rossari Private Limited Wholly Owned Subsidiary Company Interest received 5,000.00 NA 96.80 0.00 0.00
17 Rossari Biotech Limited Buzil Rossari Private Limited Wholly Owned Subsidiary Company Any other transaction Employee Cost - Recovery 1,000.00 NA 79.90 0.00 0.00
18 Rossari Biotech Limited Buzil Rossari Private Limited Wholly Owned Subsidiary Company Any other transaction Employee Cost - Reimbursement 1,000.00 NA 100.50 0.00 0.00
19 Rossari Biotech Limited Buzil Rossari Private Limited Wholly Owned Subsidiary Company Any other transaction Recovery of Expenses 1,000.00 NA 43.90 0.00 0.00
20 Rossari Biotech Limited Rossari Consumer Products Private Limited Wholly Owned Subsidiary Company Sale of goods or services 6,000.00 NA 1,016.40 3,160.90 3,759.20
21 Rossari Biotech Limited Rossari Consumer Products Private Limited Wholly Owned Subsidiary Company Any other transaction Employee Cost - Recovery 500.00 NA 10.10 0.00 0.00
22 Rossari Biotech Limited Rossari Consumer Products Private Limited Wholly Owned Subsidiary Company Any other transaction Recovery of Expenses 500.00 NA 8.60 0.00 0.00
23 Rossari Biotech Limited Tristar Intermediates Private Limited Wholly Owned Subsidiary Company Sale of goods or services 1,500.00 NA 276.40 1,012.90 259.70
24 Rossari Biotech Limited Tristar Intermediates Private Limited Wholly Owned Subsidiary Company Any other transaction Commission Income NA 100.30 0.00 0.00
25 Rossari Biotech Limited Tristar Intermediates Private Limited Wholly Owned Subsidiary Company Purchase of goods or services 25,000.00 NA 12,642.10 10,408.50 7,335.90
26 Rossari Biotech Limited Tristar Intermediates Private Limited Wholly Owned Subsidiary Company Purchase of fixed assets 250.00 NA 11.40 0.00 0.00
27 Rossari Biotech Limited Tristar Intermediates Private Limited Wholly Owned Subsidiary Company Any other transaction Employee Cost - Recovery 1,000.00 NA 267.70 0.00 0.00
28 Rossari Biotech Limited Tristar Intermediates Private Limited Wholly Owned Subsidiary Company Any other transaction Recovery of Expenses 1,000.00 NA 13.40 0.00 0.00
29 Rossari Biotech Limited Unitop Chemicals Private Limited Subsidiary Company Sale of goods or services 28,800.00 NA 3,807.50 4,672.90 3,773.40
30 Rossari Biotech Limited Unitop Chemicals Private Limited Subsidiary Company Any other transaction Commission Income 28,800.00 NA 812.20 0.00 0.00
31 Rossari Biotech Limited Unitop Chemicals Private Limited Subsidiary Company Sale of fixed assets 500.00 NA 8.30 0.00 0.00
32 Rossari Biotech Limited Unitop Chemicals Private Limited Subsidiary Company Purchase of goods or services 70,000.00 NA 24,342.90 13,087.50 13,123.10
33 Rossari Biotech Limited Unitop Chemicals Private Limited Subsidiary Company Purchase of fixed assets 500.00 NA 20.50 0.00 0.00
34 Rossari Biotech Limited Unitop Chemicals Private Limited Subsidiary Company Any other transaction Employee Cost - Recovery 3,000.00 NA 668.20 0.00 0.00
35 Rossari Biotech Limited Unitop Chemicals Private Limited Subsidiary Company Any other transaction Recovery of Expenses 3,000.00 NA 116.80 0.00 0.00
36 Rossari Biotech Limited Romakk Chemicals Private Limited Associate Sale of goods or services 600.00 NA 8.70 20.80 23.10
37 Rossari Biotech Limited Romakk Chemicals Private Limited Associate Purchase of goods or services 4,000.00 NA 1,369.50 901.90 1,313.90
38 Rossari Biotech Limited Romakk Chemicals Private Limited Associate Any other transaction Employee Cost - Recovery 200.00 NA 26.70 0.00 0.00
39 Rossari Biotech Limited Romakk Chemicals Private Limited Associate Any other transaction Recovery of Expenses NA 3.30 0.00 0.00
40 Rossari Biotech Limited K. K. Chempro (India) Private Limited Related Party to Romakk Chemicals Private Limited (subsidiary company) Any other transaction Receivables Ac NA 0.00 0.10 0.10
41 Rossari Biotech Limited INSAI CHEMPLAST (Formerly known as K K CHEMICAL INDUSTRIES) Related Party to Romakk Chemicals Private Limited (subsidiary company) Any other transaction Payable Ac (Dr.Bal) NA 0.00 0.50 0.50
42 Rossari Biotech Limited McCoy Performance Silicones Private Limited Related Party to Romakk Chemicals Private Limited (subsidiary company) Any other transaction Payable Ac (Dr.Bal) NA 0.00 0.10 0.10
43 Rossari Biotech Limited Rossari Global FZCO (Formerly known as Rossari Global DMCC) Wholly Owned Subsidiary Company Loan 3,600.00 NA 0.00 1,175.90 1,200.40 Loan 10.0 On Demand Unsecured General Business Requirement
44 Rossari Biotech Limited Rossari Global FZCO (Formerly known as Rossari Global DMCC) Wholly Owned Subsidiary Company Interest received 360.00 NA 59.90 157.90 179.90
45 Rossari Biotech Limited Rossari Global FZCO (Formerly known as Rossari Global DMCC) Wholly Owned Subsidiary Company Any other transaction Recovery of Expenses 100.00 NA 2.50 23.40 33.30
46 Rossari Biotech Limited Rossari Global FZCO (Formerly known as Rossari Global DMCC) Wholly Owned Subsidiary Company Any other transaction Corporate Guarantee Given 1,680.00 NA 0.00 1,490.80 1,511.70
47 Rossari Biotech Limited Rossari Global FZCO (Formerly known as Rossari Global DMCC) Wholly Owned Subsidiary Company Any other transaction Corporate Guarantee Commission Income 17.00 NA 7.50 0.00 0.00
48 Rossari Biotech Limited Rossari Biotech Trading FZE Step Down Wholly Owned Subsidiary Sale of goods or services 40,000.00 NA 14,964.30 3,786.80 9,130.70
49 Rossari Biotech Limited Rossari Biotech Trading FZE Step Down Wholly Owned Subsidiary Any other transaction Recovery of Expenses 50.00 NA 9.40 0.00 0.00
50 Rossari Biotech Limited Rossari Biotech Trading FZE Step Down Wholly Owned Subsidiary Any other transaction Corporate Guarantee Given 6,720.00 NA 0.00 5,963.20 6,046.70
51 Rossari Biotech Limited Rossari Biotech Trading FZE Step Down Wholly Owned Subsidiary Any other transaction Corporate Guarantee Commission Income 670.00 NA 30.10 0.00 0.00
52 Rossari Biotech Limited Unistar Thai Company Limited Step Down Wholly Owned Subsidiary Sale of goods or services 10,800.00 NA 89.00 291.70 231.30
53 Rossari Biotech Limited Unistar Thai Company Limited Step Down Wholly Owned Subsidiary Purchase of goods or services 5,500.00 NA 27.20 0.00 0.00
54 Rossari Biotech Limited Unistar Thai Company Limited Step Down Wholly Owned Subsidiary Any other transaction Recovery of Expenses 100.00 NA 0.70 0.00 0.00
55 Rossari Biotech Limited Unistar Thai Company Limited Step Down Wholly Owned Subsidiary Any other transaction Corporate Guarantee Given 8,400.00 NA 0.00 7,454.00 7,558.40
56 Rossari Biotech Limited Unistar Thai Company Limited Step Down Wholly Owned Subsidiary Any other transaction Corporate Guarantee Commission Income 84.00 NA 37.60 0.00 0.00
57 Rossari Biotech Limited K K Chem India Private Limited Related Party to Romakk Chemicals Private Limited (subsidiary company) Purchase of goods or services 500.00 NA 21.40 4.90 4.30
58 Rossari Biotech Limited Rossari International Limited Company Wholly Owned Subsidiary Company Loan 10,000.00 NA 0.00 250.30 255.70 Loan 7.2200 On Demand Unsecured General Business Requirement
59 Rossari Biotech Limited Rossari International Limited Company Wholly Owned Subsidiary Company Interest received 1,000.00 NA 8.90 7.70 17.10
60 Rossari Biotech Limited Rossari International Limited Company Wholly Owned Subsidiary Company Any other transaction Recovery of Expenses 1,000.00 NA 78.20 77.70 155.90
61 Unitop Chemicals Private Limited Gurudas Aras Independent Director Any other transaction Sitting Fees NA 1.50 0.00 0.00
62 Unitop Chemicals Private Limited Aparna Sharma Independent Director Any other transaction Sitting Fees NA 1.30 0.00 0.00
63 Unitop Chemicals Private Limited Tristar Intermediates Private Limited Fellow Subsidiary Sale of goods or services 5,000.00 NA 3,432.70 2,510.10 3,213.10
64 Unitop Chemicals Private Limited Tristar Intermediates Private Limited Fellow Subsidiary Purchase of goods or services 5,000.00 NA 2,878.50 754.30 69.70
65 Unitop Chemicals Private Limited Buzil Rossari Private Limited Fellow Subsidiary Purchase of goods or services 100.00 NA 0.00 5.50 12.00
66 Unitop Chemicals Private Limited Buzil Rossari Private Limited Fellow Subsidiary Any other transaction Purchase of fixed assets 100.00 NA 2.50 0.00 0.00
67 Unitop Chemicals Private Limited Buzil Rossari Private Limited Fellow Subsidiary Any other transaction Reimbursement 50.00 NA 20.10 0.00 0.00
68 Unitop Chemicals Private Limited Hextar Unitop SDN.BHD. Joint Venture Sale of goods or services 600.00 NA 257.90 29.90 72.50
69 Unitop Chemicals Private Limited Romakk Chemicals Private Limited Associate of Holding Company Sale of goods or services 125.00 NA 12.40 0.00 0.00
70 Unitop Chemicals Private Limited Romakk Chemicals Private Limited Associate of Holding Company Purchase of goods or services 1,500.00 NA 92.20 0.00 108.70
71 Unitop Chemicals Private Limited Glad Properties (India) Private Limited Promoter Group Company Any other transaction Rent 24.00 NA 10.20 2.20 0.00
72 Tristar Intermediates Private Limited Gurudas Aras Independent Director Any other transaction Sitting Fees NA 0.50 0.00 0.00
73 Tristar Intermediates Private Limited Buzil Rossari Private Limited Fellow Subsidiary Purchase of goods or services 100.00 NA 0.00 1.90 3.80
74 Tristar Intermediates Private Limited Buzil Rossari Private Limited Fellow Subsidiary Any other transaction Reimbursement Expenses (Employee) 50.00 NA 6.30 0.00 0.00
75 Tristar Intermediates Private Limited Romakk Chemicals Private Limited Fellow Subsidiary Sale of goods or services 125.00 NA 0.00 0.10 0.00
76 Buzil Rossari Private Limited Rockdude Impex Private Limited Related Party of Fellow Subsidiary Sale of goods or services 10,000.00 NA 1,199.10 585.50 560.40
77 Buzil Rossari Private Limited Rockdude Impex Private Limited Related Party of Fellow Subsidiary Purchase of goods or services 10,000.00 NA 1,488.20 (4,664.30) (2,230.20)
78 Romakk Chemicals Private Limited Nitin Sethi Key Managerial Personnel Remuneration 50.00 NA 25.00 0.00 0.00
79 Romakk Chemicals Private Limited Amit Malhotra Key Managerial Personnel Remuneration 24.00 NA 12.00 0.00 0.00
80 Romakk Chemicals Private Limited Gurudas Aras Independent Director Any other transaction Sitting Fees NA 1.30 0.00 0.00
81 Romakk Chemicals Private Limited Esha Achan Independent Director Any other transaction Sitting Fees NA 1.30 0.00 0.00
82 Romakk Chemicals Private Limited K K Chem India Private Limited Enterprises on which Director or their relatives are able to exercise significant influence Sale of goods or services 10.00 NA 0.00 4.00 0.00
83 Romakk Chemicals Private Limited K K Chem India Private Limited Enterprises on which Director or their relatives are able to exercise significant influence Purchase of goods or services 500.00 NA 141.50 28.20 87.30
84 Romakk Chemicals Private Limited Nitin Sethi (HUF) Enterprises on which Director or their relatives are able to exercise significant influence Any other transaction Rent 21.00 NA 10.50 0.70 1.60
85 Romakk Chemicals Private Limited Sumant Agrawal (HUF) Enterprises on which Director or their relatives are able to exercise significant influence Any other transaction Rent 21.00 NA 10.50 0.80 1.90
86 Rossari Global FZCO (Formerly known as Rossari Global DMCC) Sunil Chari Director Remuneration As per the Companies Act, 2013 48.80 0.00 0.00
87 Rossari Global FZCO (Formerly known as Rossari Global DMCC) Yashika Chari Relative of Director Remuneration As per the Companies Act, 2013 44.60 0.00 0.00
88 Rossari Global FZCO (Formerly known as Rossari Global DMCC) Rupesh Ruparelia Manager Remuneration As per SEBI LODR,2015 9.30 0.00 0.00
89 Rossari Global FZCO (Formerly known as Rossari Global DMCC) Rossari Biotech Trading FZE Wholly Owned Subsidiary Company Loan 959.80 NA 103.60 255.60 156.60 Loan 10.0 On Demand Unsecured General Business Requirement
90 Rossari Global FZCO (Formerly known as Rossari Global DMCC) Rossari Biotech Trading FZE Wholly Owned Subsidiary Company Interest received 96.00 NA 10.10 7.30 2.60
91 Rossari Global FZCO (Formerly known as Rossari Global DMCC) Unistar Thai Company Limited Wholly Owned Subsidiary Company Loan 863.80 NA 0.00 281.20 287.00
92 Rossari Global FZCO (Formerly known as Rossari Global DMCC) Unistar Thai Company Limited Wholly Owned Subsidiary Company Interest received 86.00 NA 14.30 7.50 4.80
93 Rossari International Limited Company Rupesh Ruparelia Manager Remuneration As per SEBI LODR,2015 7.60 0.00 0.00
94 Rossari Biotech Trading FZE Edward Menezes Director Remuneration As per the Companies Act, 2013 61.90 0.00 0.00
95 Rossari Biotech Trading FZE Yash Chari Director Remuneration As per the Companies Act, 2013 47.00 0.00 0.00
96 Rossari Biotech Limited Prasad Gadkari Director of Subsidiary Remuneration As per the Companies Act, 2013 and SEBI LODR,2015 69.20 0.00 0.00
97 Rossari Biotech Limited Pravin Deokar Director of Subsidiary Remuneration As per the Companies Act, 2013 and SEBI LODR,2015 13.90 0.00 0.00
98 Tristar Intermediates Private Limited Sanjay Marballi Director Remuneration As per the Companies Act, 2013 and SEBI LODR,2015 67.60 0.00 0.00
99 Tristar Intermediates Private Limited Krishna Kumar Tiwari Director Remuneration As per the Companies Act, 2013 and SEBI LODR,2015 12.50 0.00 0.00
Total value of transaction during the reporting period 73,834.80





Format for Disclosing Outstanding Default on Loans and Debt Securities

Amount in (Lakhs)

<
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0.00